- Home
- SSBI vs ABOS Comparison
SSBI vs ABOS Comparison
Compare SSBI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBI
- ABOS
- Stock Information
- Founded
- SSBI 1982
- ABOS 1996
- Country
- SSBI United States
- ABOS United States
- Employees
- SSBI N/A
- ABOS N/A
- Industry
- SSBI Major Banks
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- SSBI Finance
- ABOS Health Care
- Exchange
- SSBI Nasdaq
- ABOS Nasdaq
- Market Cap
- SSBI 79.2M
- ABOS 85.4M
- IPO Year
- SSBI 2006
- ABOS 2021
- Fundamental
- Price
- SSBI $11.89
- ABOS $1.49
- Analyst Decision
- SSBI
- ABOS Strong Buy
- Analyst Count
- SSBI 0
- ABOS 3
- Target Price
- SSBI N/A
- ABOS $6.33
- AVG Volume (30 Days)
- SSBI 11.0K
- ABOS 270.7K
- Earning Date
- SSBI 07-29-2025
- ABOS 08-12-2025
- Dividend Yield
- SSBI 0.34%
- ABOS N/A
- EPS Growth
- SSBI N/A
- ABOS N/A
- EPS
- SSBI N/A
- ABOS N/A
- Revenue
- SSBI $27,567,000.00
- ABOS N/A
- Revenue This Year
- SSBI N/A
- ABOS N/A
- Revenue Next Year
- SSBI N/A
- ABOS N/A
- P/E Ratio
- SSBI N/A
- ABOS N/A
- Revenue Growth
- SSBI N/A
- ABOS N/A
- 52 Week Low
- SSBI $5.68
- ABOS $0.86
- 52 Week High
- SSBI $12.60
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- SSBI 54.43
- ABOS 57.31
- Support Level
- SSBI $11.43
- ABOS $1.35
- Resistance Level
- SSBI $11.85
- ABOS $1.60
- Average True Range (ATR)
- SSBI 0.28
- ABOS 0.10
- MACD
- SSBI -0.08
- ABOS 0.01
- Stochastic Oscillator
- SSBI 46.00
- ABOS 78.05
About SSBI Summit State Bank
Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.